← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Meister Keith A.
10% Owner | Director
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001307631
Purchase history
- Companies traded
- 2
- Purchases · 12M
- 4
- Purchases · 24M
- 8
- Average purchase
- $12.6M
- Median purchase
- $6.5M
- Gross purchase value
- $100.4M
Companies: GeneDx Holdings Corp. | Vestis Corp
8 SEC accession(s) · 8 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-05-15 | GeneDx Holdings Corp. | WGS | Director | 10% Owner | $13.8M | Open filing |
| 2026-05-11 | GeneDx Holdings Corp. | WGS | Director | 10% Owner | $46.8M | Open filing |
| 2026-03-05 | GeneDx Holdings Corp. | WGS | Director | 10% Owner | $13.5M | Open filing |
| 2025-12-17 | Vestis Corp | VSTS | Director | 10% Owner | $6.9M | Open filing |
| 2025-05-28 | Vestis Corp | VSTS | Director | 10% Owner | $4.8M | Open filing |
| 2025-05-16 | GeneDx Holdings Corp. | WGS | Director | 10% Owner | $3.0M | Open filing |
| 2025-05-12 | Vestis Corp | VSTS | Director | 10% Owner | $6.1M | Open filing |
| 2025-05-12 | GeneDx Holdings Corp. | WGS | Director | 10% Owner | $5.6M | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 5Developing | 62.5% (5/8) | 80.0% (4/5) | +7.9% | +8.9% | -4.0% |
| 20D | 5Developing | 62.5% (5/8) | 60.0% (3/5) | +14.4% | +17.2% | -15.8% |
| 60D | 5Developing | 62.5% (5/8) | 80.0% (4/5) | +71.4% | +52.6% | -48.2% |
| 120D | 3Small Sample | 50.0% (3/6) | 66.7% (2/3) | +89.6% | +67.0% | -2.9% |
Research patterns
- First purchase in 12M
- 0/6
- Large purchase ≥ $100k
- 8/8
- Cluster buying · 15D
- 8/8
- Buying the dip
- 5/5
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.